NCT01046253View on ClinicalTrials.gov

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Healthy
Interventions
DRUG

Lansoprazole

30 mg Delayed-Release Capsules

DRUG

Prevacid®

30 mg Delayed-Release Capsule

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01046253 - Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study | Biotech Hunter | Biotech Hunter